Paper36985487
Supermolecule-Drug Conjugates Based on Acid-Degradable Polyrotaxanes for pH-Dependent Intracellular Release of Doxorubicin.
Tamura A and 2 others. Molecules, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Supermolecule-Drug Conjugates Based on Acid-Degradable Polyrotaxanes for pH-Dependent Intracellular Release of Doxorubicin. Papers, record 36985487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36985487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Supermolecule-Drug Conjugates Based on Acid-Degradable Polyrotaxanes for pH-Dependent Intracellular Release of Doxorubicin.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rotaxanes | Major topic |
| Doxorubicin | |
| Polyethylene Glycols | |
| Drug Carriers | |
| Acids | |
| Hydrogen-Ion Concentration |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP20H04527 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34971694 | Evolution of drug delivery systems: From 1950 to 2020 and beyond. | J Control Release | 2022 | https://conductscience.org/library/papers/34971694 | PubMed |
| 2 | 26417911 | Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane as a Long Circulating High Relaxivity MRI Contrast Agent. | ACS Appl Mater Interfaces | 2015 | https://conductscience.org/library/papers/26417911 | PubMed |
| 3 | 27877888 | Lysosomal pH-inducible supramolecular dissociation of polyrotaxanes possessing acid-labile N-triphenylmethyl end groups and their therapeutic potential for Niemann-Pick type C disease. | Sci Technol Adv Mater | 2016 | https://conductscience.org/library/papers/27877888 | PubMed |
| 4 | 28346375 | Liposomal Formulations in Clinical Use: An Updated Review. | Pharmaceutics | 2017 | https://conductscience.org/library/papers/28346375 | PubMed |
| 5 | 24874289 | State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. | J Control Release | 2014 | https://conductscience.org/library/papers/24874289 | PubMed |
| 6 | 16551060 | Biocleavable polyrotaxane-plasmid DNA polyplex for enhanced gene delivery. | J Am Chem Soc | 2006 | https://conductscience.org/library/papers/16551060 | PubMed |
| 7 | 23740531 | Synthesis of paclitaxel-conjugated β-cyclodextrin polyrotaxane and its antitumor activity. | Angew Chem Int Ed Engl | 2013 | https://conductscience.org/library/papers/23740531 | PubMed |
| 8 | 17904680 | In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. | J Control Release | 2007 | https://conductscience.org/library/papers/17904680 | PubMed |
| 9 | 21048526 | Doxorubicin pathways: pharmacodynamics and adverse effects. | Pharmacogenet Genomics | 2011 | https://conductscience.org/library/papers/21048526 | PubMed |
| 10 | 18995930 | Studies on self-aggregation of anthracycline drugs by restrained molecular dynamics approach using nuclear magnetic resonance spectroscopy supported by absorption, fluorescence, diffusion ordered spectroscopy and mass spectrometry. | Eur J Med Chem | 2009 | https://conductscience.org/library/papers/18995930 | PubMed |
| 11 | 35536230 | Cografting of Zwitterionic Sulfobetaines and Cationic Amines on β-Cyclodextrin-Threaded Polyrotaxanes Facilitates Cellular Association and Tissue Accumulation with High Biocompatibility. | ACS Biomater Sci Eng | 2022 | https://conductscience.org/library/papers/35536230 | PubMed |
| 12 | 10099151 | Synthesis of theophylline-polyrotaxane conjugates and their drug release via supramolecular dissociation. | J Control Release | 1999 | https://conductscience.org/library/papers/10099151 | PubMed |
| 13 | 9700924 | Deciphering the fluorescence signature of daunomycin and doxorubicin. | Biophys Chem | 1998 | https://conductscience.org/library/papers/9700924 | PubMed |
| 14 | 19548866 | Doxorubicin: the good, the bad and the ugly effect. | Curr Med Chem | 2009 | https://conductscience.org/library/papers/19548866 | PubMed |
| 15 | 33233774 | Functionalization of Polyethyleneimine with Hollow Cyclotriveratrylene and Its Subsequent Supramolecular Interaction with Doxorubicin. | Molecules | 2020 | https://conductscience.org/library/papers/33233774 | PubMed |
| 16 | 29472567 | Polyrotaxane-based supramolecular theranostics. | Nat Commun | 2018 | https://conductscience.org/library/papers/29472567 | PubMed |
| 17 | 28299982 | Oligo(ethylene glycol)-modified β-cyclodextrin-based polyrotaxanes for simultaneously modulating solubility and cellular internalization efficiency. | J Biomater Sci Polym Ed | 2017 | https://conductscience.org/library/papers/28299982 | PubMed |
| 18 | 36509286 | Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling. | JCI Insight | 2022 | https://conductscience.org/library/papers/36509286 | PubMed |
| 19 | 33795852 | The evolution of commercial drug delivery technologies. | Nat Biomed Eng | 2021 | https://conductscience.org/library/papers/33795852 | PubMed |
| 20 | 23332177 | Cellular internalization and gene silencing of siRNA polyplexes by cytocleavable cationic polyrotaxanes with tailored rigid backbones. | Biomaterials | 2013 | https://conductscience.org/library/papers/23332177 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39318465 | Bridging host-guest chemistry with molecule chemistry-covalent organic polyrotaxanes (COPRs): from synthesis to inactivation of bacterial pathogens. | RSC Adv | 2024 | https://conductscience.org/library/papers/39318465 | PubMed |
| 39273469 | The Many Faces of Cyclodextrins within Self-Assembling Polymer Nanovehicles: From Inclusion Complexes to Valuable Structural and Functional Elements. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273469 | PubMed |
| 38274164 | Supramolecular nanoarchitectonics of propionylated polyrotaxanes with bulky nitrobenzyl stoppers for light-triggered drug release. | RSC Adv | 2024 | https://conductscience.org/library/papers/38274164 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36985487
GET https://conductscience.org/api/papers/v1/36985487/references?page=2